Fibroblast growth factor homologous factors (FHFs) have been implicated in limb and nervous system development. In this paper we describe the expression of the cFHF-4 gene during early chicken development. cFHF-4 is expressed in the paraxial mesoderm, lateral ridge, and, most prominently, in the posterior-dorsal side of the base of each limb bud. The expression pattern of cFHF-4 at the base of the limbs is not altered by tissue grafts containing the zone of polarizing activity (ZPA), by implants of Shh-expressing cells, or by implants of beads containing retinoic acid, nor does it depend on the distal growth of the limb as it is not altered in limb buds that are surgically truncated. In three chicken mutants affecting limb patterning ± talpid 2 , limbless, and wingless ± altered patterns of cFHF-4 expression are correlated with abnormal nerve plexus formation and altered patterns of limb bud innervation. Similarly, ectopic expression of cFHF-4 is correlated with a local induction of limb-like innervation patterns when beads containing FGF-2 are implanted in the¯ank. In these experiments, both ectopic innervation and ectopic expression of cFHF-4 in the¯ank were observed regardless of the size of the FGF-2-induced outgrowths. By contrast, ectopic expression of Shh and HoxD13 are seen only in the larger FGF-2-induced outgrowths. Taken together, these data suggest that cFHF-4 regulates or is coregulated with early events related to innervation at the base of the limbs. q
Introduction
Fibroblast growth factor homologous factors (FHF-1 through -4; equivalently form a distinct branch of the FGF family, and have been implicated in the development of the nervous system and the limbs (Smallwood et al., 1996; Hartung et al., 1997; Mun Äoz-Sanjua Ân et al., 1999 , 2000 . The FHFs exhibit a complex pattern of gene regulation through differential promoter use and splicing of alternate 5 H exons (Hartung et al., 1997; Yamamoto et al., 1998; Mun Äoz-Sanjua Ân et al., 2000) . Alternative splicing generates FHF isoforms in which the amino termini differ in both length and sequence. In both mice and chickens, several of the isoforms show distinct and non-overlapping tissue distributions (Yamamoto et al., 1998; Mun Äoz-Sanjua Ân et al., 1999 , 2000 .
We previously reported the identi®cation of two spliced isoforms of chicken FHF-4, termed cFHF-4(1A) and cFHF-4(1B) (Mun Äoz-Sanjua Ân et al., 2000; species designations: c, chicken; m, mouse; h, human) . In the mouse, the two corresponding orthologues have different expression patterns in various tissues including the adult brain (Yamamoto et al., 1998; Mun Äoz-Sanjua Ân et al., 2000) . The two isoforms also show distinct subcellular localization when the proteins are produced in transfected cells: the FHF-4(1A) isoform localizes primarily to the nucleus, whereas the FHF-4(1B) isoform appears exclusively in the cytosol (Mun Äoz-Sanjua Ân et al., 2000) . The functional signi®cance of this differential subcellular localization is unclear, but it would presumably affect the activity and/or secretory properties of these proteins.
In this paper, we report the expression pattern of the cFHF-4 gene during early chicken development. The cFHF-4 gene is expressed in the caudal paraxial mesoderm, the lateral ridge, the ®rst brachial arch, the abdominal wall, the base of the limbs, and the limbs themselves. The early onset of cFHF-4 expression at the base of the limbs, and its spatial proximity to the developing nerve plexus suggests the possibility that cFHF-4 regulates or is coregulated with the initial events in limb innervation.
Many classical embryological experiments have been conducted to elucidate the role that various tissues or structures play in the establishment of a nerve plexus and in the control of axonal trajectories within the limb. However, these experiments have yet to de®ne the role of the limb bud in plexus formation and the dorsoventral separation of the axons as they exit the plexus (Hollyday, 1981 (Hollyday, , 1995 Lance-Jones and Landmesser, 1981a,b; Swanson and Lewis, 1982; Neset et al., 1985; Summerbell, 1985, 1988; Lance-Jones, 1986; Landmesser and Honig, 1986; Ferns and Hollyday, 1993) . Although these two processes are known to be independent of limb outgrowth and muscle tissue Tosney and Landmesser, 1984; Noakes et al., 1986; Keynes et al., 1987) , the molecular cues that control them are largely unknown.
In this report, we show that the expression of cFHF-4 at the base of the limb bud is independent of limb outgrowth, that it is altered in three mutants affecting limb development (talpid 2 , limbless, and wingless), and that the expression of cFHF-4 in these mutant embryos is correlated with abnormal limb innervation patterns. We also show that implants of FGF-2-containing beads induce localized cFHF-4 expression in the¯ank, and that this induction correlates with local alterations in axonal growth. However, ectopic expression of FHF-4 from a replication-competent retrovirus does not perturb axonal growth or induce any morphologic anomalies in early limb development, suggesting that if FHF-4 signaling plays a role in these processes it may be subject to regulation by additional factors that compensate for its overexpression.
Results

Expression of cFHF-4 in the chicken embryo
The distribution of cFHF-4 transcripts was determined in chicken embryos between stages 16 and 31 by whole-mount in situ hybridization using riboprobes that encompass exons 2±5 and which therefore detect both splice isoforms of this gene (Mun Äoz-Sanjua Ân et al., 2000) . In situ hybridization with ®rst exon probes show that the transcripts present in the tissues described below correspond to the cFHF-4 (1A) isoform.
Expression of cFHF-4 is ®rst detected at stages 23±24, at the base of the limb buds, in the facial primordia, the ®rst brachial arch, and the olfactory epithelium. cFHF-4 expression during craniofacial patterning will be described elsewhere (Mun Äoz-Sanjua Ân et al., in preparation) . Outside the face, cFHF-4 expression is most prominent in two adjacent domains at the base of the wings and legs, in the posterior dorsal mesoderm (Fig. 1A±C ). We will refer to these as expression domains 1 and 2, as illustrated in Fig. 1C . Domain 1 shows graded expression along the anterior/ posterior (A/P) axis of the wings and legs, with highest transcript levels posteriorly (Fig. 1A±C) . Domain 1 appears to mark the proximal limb boundary, as evidenced by comparison with the expression pattern of cLmx-1, which is expressed throughout the dorsal limb mesoderm ( Fig. 1A ; Riddle et al., 1995; Vogel et al., 1995) . Domain 2 extends into the limb bud along the posterior dorso/ventral (D/V) boundary, at the junction of the limb bud and body wall; this domain expands anteriorly and distally within the limb at later stages (Fig. 1B) . Both domains of cFHF-4 expression at the base of the limbs are adjacent to the site of plexus formation as determined by double-labeling with anti-tubulin TuJ1 antibody which recognizes all motor and sensory axons (mAb TuJ1; Moody et al., 1989 ; Fig. 1D,E) .
The expression domain at the base of the limbs persists until stages 30±31, the latest stages analyzed. Within the limb proper, there are two narrow stripes of cFHF-4 expression from stages 25 to 28, which run along the anterior and posterior D/V boundaries of the limbs midway through the limb buds (not shown). There is also distal mesenchymal expression in the autopod beginning at stage 26 (arrowheads in Fig. 1C ). The caudal-most paraxial mesoderm (from the leg buds to the tail bud) express cFHF-4 in a segmented fashion from stages 25 to 28 (Fig. 1F ). Cross sections of this region reveal that cFHF-4 expression is present at highest levels in the paraxial mesoderm, outside the neural tube (Fig. 1G ). The neural tube shows weak mediolateral expression during these stages (not shown). cFHF-4 is also expressed rostral to the wings in the lateral ridge mesoderm at stages 24±28, the ®rst brachial arch, the genital ridge area at stages 24±30, and the edges of the abdominal wall (not shown).
Expression of cFHF-4 in talpid 2 embryos
To investigate whether the expression of cFHF-4 at the base of the limbs is dependent on limb initiation, outgrowth, and patterning, cFHF-4 expression was analyzed in the chicken mutants talpid 2 , limbless, and wingless. As described below, this analysis reveals a correlation between altered expression of cFHF-4 and the limb innervation patterns in these mutants.
Talpid 2 is a recessive lethal mutation which has been best characterized in the context of limb development (Goetinck and Abbott, 1964; Dvorak and Fallon, 1991) . Talpid 2 embryos exhibit a variable degree of polydactyly and syndactyly, and the talpid 2 defects are associated with alterations in the Sonic Hedgehog (Shh) signaling pathway (Dvorak and Fallon, 1991; Caruccio et al., 1999) . In talpid 2 , the size of the limb bud is expanded anteriorly from stage 20 onwards (Figs. 2 and 3A, B) . The domain 2 expression of cFHF-4 at the base of the wings in talpid 2 embryos is expanded anteriorly, although this expansion does not reach the anterior-most domain. In contrast, expression of cFHF-4 in domain 1 of talpid 2 legs expands to the anterior D/V boundary, although this expression is patchy. Domain 2 appears unaltered in talpid 2 legs. The distal mesenchymal expression of cFHF-4 in the autopod is also enlarged (compare Fig. 2A with Fig.  2B,C) . In contrast, the cLmx-1 gene is expressed uniformly across the dorsal talpid 2 limb mesoderm (Fig. 2D ).
Limb bud innervation is abnormal in talpid 2 embryos
The expanded expression of cFHF-4 in the limbs of talpid 2 embryos is accompanied by an altered innervation pattern in the limbs of this mutant, as revealed by immunostaining whole-mount embryos at stages 19±30 for axonal There is minor variability in the ectopic expression of cFHF-4 in the different embryos, both in the wing and leg buds. In (B), in the wing, the cFHF-4 expression domain 2 is expanded, whereas domain 1 remains unchanged. In the leg, domain 2 is unchanged, whereas domain 1 is largely expanded. In (C) there is patchy anterior expression of cFHF-4 in the leg buds. Arrowhead in (C) points to the expanded expression in the autopod. (D) Expression of the cLmx-1 gene in a stage 20 talpid 2 embryo. cLmx-1 is expressed uniformly in the dorsal mesoderm of the expanded limb bud. projections. Two aspects of limb innervation are of particular interest for this study: (1) the formation of the plexus at the base of the limbs; and (2) the proximal innervation pattern along the A/P axis of the limbs.
The brachial plexus is expanded in talpid 2 embryos, beginning as early as stages 19±20 in the wings. In the talpid 2 embryo, there is one extra segment rostral to the wing, and therefore we have labeled the cervical spinal nerves C1±C16, as opposed to the normal numbering, C1± C15. At stages 19±20, spinal nerves from cervical (C13±16) and thoracic (T1) segments contribute to the brachial plexus in the talpid 2 embryo (Fig. 3B) ; in the wild type, contributions come from C14±15 and T1 (Fig. 3A) . At stages 23±25, spinal nerves from segments C12±C16 and T1±T2 contribute to the brachial plexus in talpid 2 embryo, whereas in the wild type, the plexus is formed by spinal nerves from C13± 15 and T1±T2 segments (compare Fig. 3C with D). In laterstage talpid 2 embryos, the axons frequently enter the wings from an anteriorly biased direction, in contrast to the pattern during normal development, where there is a strong posterior bias in the initial trajectories of the axons within the limbs (compare Fig. 3E with G,H). In talpid 2 embryos, the ®ne branching that occurs more distally within the limbs appears normal for some nerves, although the number of nerves is larger and the relative thickness of the axonal bundles is smaller than in wild-type limbs (not shown).
In the talpid 2 leg, the overall enlargement of the plexus region is smaller than in the wing. In most talpid 2 embryos, axons from T7 and LS1 contribute to the crural plexus, whereas in the wild type, only part of LS1 contributes to this plexus (Fig. 3J ). In the wild type, during the initial migration of the axons from the crural plexus and the sciatic plexus, axons do not mix as they enter the limbs ( Fig. 3F ; Lance-Jones and Landmesser, 1981a; Honig et al., 1986) . In talpid 2 embryos, the distinction between the crural plexus and the sciatic plexus is less apparent, and axons appear to exit both plexuses uniformly across the limb bud (Fig. 3I,J) . In a subset of talpid 2 embryos, there appears to be a mirror image pattern in the initial branching of the axons (not shown). In contrast to the alterations observed in the axonal projections along the anterior±posterior axis of the talpid 2 limbs, the axonal projections along the dorsoventral axis appear unaltered (not shown).
Expression of cFHF-4 in response to ZPA grafts, retinoic acid, and Shh-N-expressing cells
The asymmetric pattern of cFHF-4 expression at the base of the limb suggests that it is controlled by the limb-derived signals that are responsible for the generation of the A/P axis. In a ®rst experiment to test this hypothesis, we grafted stage 19±20 zone of polarizing activity (ZPA) fragments to the anterior proximal domain of recipient leg buds from stage 19±20 embryos (Tickle, 1981) . Under these conditions, a variable degree of preaxial outgrowth was observed, but expression of cFHF-4 was not altered (n 19). In a second set of experiments, pellets of COS cells producing the amino terminal domain of Shh (Shh-N) or beads soaked in all-trans retinoic acid (RA) at different concentrations (0.1 or 0.5 mg/ml of RA) were implanted in the anterior, proximal domain of wing buds at stages 19±20. The developmental effect of the grafts was assayed by the presence of duplicated shoulders and ectopic anterior expression of cShh in response to RA-soaked beads, and expanded limbs in the case of grafts of Shh-N-expressing cells (not shown). In all cases examined the expression pattern of cFHF-4 was unchanged (0/7 with Shh-N and 0/33 with RA beads). These experiments suggest that the asymmetric pattern of cFHF-4 expression is determined by signals derived from the early posterior limb ®eld or the lateral plate.
Expression of cFHF-4 in the absence of the limb outgrowth, and in limbless and wingless mutant embryos
To test whether the expression of cFHF-4 at the base of the limbs is regulated by limb outgrowth, we surgically ablated the right wings of stage 19 embryos and let the embryos develop for an additional 48 h. In all cases analyzed (9/9), the expression of cFHF-4 was unaltered (Fig. 4A) , demonstrating that distal outgrowth of the limb after stage 19 is not required for correct cFHF-4 expression. However, limb ®eld speci®cation and ZPA establishment takes place at or before stage 16 (Martin, 1998) . Therefore, to test whether limb outgrowth prior to stage 19 could have an effect on cFHF-4 expression, we analyzed its expression in limbless and wingless mutant embryos, which affect the formation and maintenance of the AER, respectively (Fallon et al., 1983; Carrington and Fallon, 1984; Grieshammer et al., 1996; Noramly et al., 1996; Ros et al., 1996) . In limbless embryos there is no detectable Shh or Fgf-8 expression in the limbs at any stage (Grieshammer et al., 1996; Ros et al., 1996) . Both limbless and wingless limbs are molecularly dorsalized (Riddle et al., 1995; Vogel et al., 1995; Ros et al., 1996; Logan et al., 1997) , and give rise to bidorsal structures when recombinant limbs are formed by adding a wild type ectodermal jacket to the mesoderm from these mutants (Grieshammer et al., 1996; Ros et al., 1996; J.F. Fallon, unpublished results) . Analysis of cFHF-4 expression in these mutants can therefore reveal whether the D/V asymmetry in cFHF-4 expression is directed by D/V patterning cues derived from the limb.
In six limbless and ®ve wingless embryos examined, the expression of cFHF-4 was present only in the posterior dorsal mesoderm, although at a lower level than that observed in the sibling wild type embryos (Fig. 4B) . Domain 2 of cFHF-4 expression at the base of the limbs is greatly reduced in the wings in both limbless and wingless embryos (arrow in Fig. 4B for a limbless embryo) and it is absent in the legs (arrowhead in Fig. 4B ). Expression of cFHF-4 elsewhere is normal (not shown). Implantation of a bead containing FGF-2 into the limbless wing leads to distal limb outgrowth (n 6, Fig. 4D ; Ros et al., 1996) , but did not signi®cantly alter cFHF-4 expression (n 3, not shown). These observations further support the idea that the D/V and A/P asymmetry in cFHF-4 expression at the base of the limbs derives from signals originating in the lateral plate rather than the limbs.
Innervation defects in the limbless embryo
To determine whether plexus formation and dorsal and ventral axonal branch separation take place in the absence of limb outgrowth, we analyzed the patterns of limb innervation in limbless embryos. In these embryos, the brachial plexus is well developed at stages 21±24, although it is often expanded to include spinal nerve C12 (Fig. 4D) . The crural and sciatic plexuses also form, although the sciatic plexus is largely missing contributions from spinal nerves LS7 and LS8 (Fig. 4E,F) . D/V branch separation is observed in the brachial and crural plexuses, although in the crural plexus the ventral branch is small (arrowheads in Fig. 4C,E) . Axons exiting the plexuses appear disorganized as they migrate into the peripheral tissue.
FGF-2 beads induce cFHF-4 expression in the¯ank
Ectopic limbs can be induced in the¯ank with beads soaked in FGFs and these limbs are innervated (Cohn et al., 1995) . We therefore asked whether ectopic limb buds induced by FGF-2 bead implants exhibit expression of cFHF-4, and, if so, in what pattern. In a ®rst set of experiments, beads soaked in FGF-2 (0.5 mg/ml) were implanted in the¯ank of 30 stage 13±14 embryos producing ectopic limbs in 12 of them. When the embryos were processed at stages 27±28, 12 of 12 ectopic limbs showed ectopic cFHF-4 expression in a mirror image pattern relative to the normal posterior pattern of expression, as has been previously reported for other genes expressed asymmetrically along the A/P axis ( Fig. 5A ; Cohn et al., 1995) . In four of 30 embryos, FGF-2 beads induced a small outgrowth which did not develop into a full limb. In these cases, cFHF-4 was ectopically expressed in a manner similar to that seen in embryos where a fully developed limb had been induced (Fig. 5B,C) .
FGF-2 beads implanted at various levels along the¯ank at stages 15±17 ef®ciently produced small outgrowths, but not fully formed limbs. In 25 of 30 embryos implanted at stages 15±17, cFHF-4 expression was strongly induced in the¯ank, generally ventral to its normal expression domain (Fig. 5C,D) . Even in embryos in which no detectable outgrowth was observed ± usually ones in which the beads were implanted caudal to the wing bud ± cFHF-4 was still induced. In those cases, there was an expansion of the cFHF-4 expression domain posterior to the wing (Fig.  5D ). In the outgrowths induced anterior to the leg buds, the asymmetric expression of cFHF-4 was found rostral to the outgrowth (arrows in Fig. 5B,C) . The induction of cFHF-4 expression by FGF-2 beads is restricted to thē ank. Beads placed within the limb itself at stages 20±21 or in the facial primordia failed to elicit any changes in cFHF-4 expression (not shown).
FGF-2 beads induce defects in axonal guidance: correlation with cFHF-4, cLmx-1, cHoxD13 and cShh expression
To test whether the induced expression of cFHF-4 in thē ank in response to FGF-2 beads was correlated with abnormal nerve outgrowth, we analyzed the innervation patterns in these embryos. In 12 of 15 cases analyzed, the innervation patterns in the¯ank were signi®cantly altered (Fig. 6A±D) , and in 10 of 10 cases in which the pattern of innervation and the pattern of cFHF-4 expression were simultaneously analyzed, both were found to be altered (Fig. 6E,F) .
A plexus-like structure can be induced in the¯ank at any location between the limbs in response to an FGF-2 bead (Fig. 6A±D) . Rostral to the leg bud, where most of the beads were placed and where the bead typically induced a small outgrowth, the axons were observed to preferentially enter the outgrowths from the rostral side where expression of cFHF-4 is most prominent (Fig. 6D±F) . In those cases where a large outgrowth was contiguous with the leg bud, a new plexus appeared to form (arrow in Fig. 6C ). In these embryos, the crural plexus was also affected, and some of the axons changed direction and innervated the distal domains of the outgrowths. In 11 cases in which the FGF-2 bead failed to induce an obvious tissue outgrowth, abnormalities in axonal guidance were still observed. Under the conditions of these experiments, in which the FGF-2 beads reside in the ventral¯ank mesoderm, the defects were con®ned to the ventral axons, which appeared to branch out across areas which are normally devoid of innervation (Fig. 6A,E) .
In order to determine the extent of the limb initiation program following FGF-2 bead implantations under these conditions, we analyzed the expression pattern of the cLmx-1, cShh and cHoxD13 genes. The cLmx-1 gene has been implicated in the control of dorsal cell fates (Riddle et al., 1995; Vogel et al., 1995) . In six of 14 embryos, cLmx-1 was ectopically expressed in response to FGF-2, typically at a lower level than in the normal limbs (Fig. 5F ). Ectopic expression of cShh and cHoxD13 was detected only in those embryos with the largest outgrowths (n 1=6 for cShh, Fig. 7A,B ; n 2=6 for cHoxD13, Fig. 7E,F) . In cases in which the beads induced a small outgrowth, there was no detectable ectopic cShh expression (n 0=5, Fig. 7C ,D) or cHoxD13 expression (n 0=4, Fig. 7G,H) . Alterations in axonal outgrowth were observed in the crural plexus, in embryos in which no ectopic cShh or cHoxD13 transcripts were observed (Fig. 7B,D,F,H) .
Effect of widespread ectopic expression of FHF-4
As one test of the potential role of the cFHF-4 gene during limb morphogenesis and innervation, the mFHF-4(1A) and cFHF-4(1B) isoforms were ectopically expressed using replication-competent RCAS(A) retroviruses (Hughes et al., 1987) . Misexpression of mFHF-4(1A)/RCAS(A) construct was performed by grafting virally infected CEFs in the¯ank LPM (n 54). Innervation patterns were analyzed in response to the grafts at stages 27±31 (n 30), and some embryos were allowed to develop to day 10 for cartilage preparations (n 9). No anomalies in axonal patterning or in chondrogenesis were observed in any of the embryos analyzed. Misexpression of the cFHF-4(1B) isoform was performed either by grafting cFHF-4(1B)/RCAS(A) infected CEFs in the¯ank LPM of stage 13±16 embryos, or by injection of a high-titer stock of the virus in the¯ank LPM of stage 12±14 embryos (Morgan and Fekete, 1995) . These embryos showed no axonal innervation defects at stages 27±31 (n 15, grafts; n 14, injections), or cartilage defects at day 10 (n 5, injections). Control grafts with CEFs alone (n 12) or CEFs infected with a hFHF-1(1A)/RCAS(A) virus (n 17) similarly did not produce any anomalies. of cLmx-1 expression. cFHF-4 expression at the limb base begins at the time when the axons leave the plexus and continues throughout the period of axon outgrowth into the limb bud. To address the mechanisms controlling the asymmetric expression of cFHF-4 at the limb base, we analyzed cFHF-4 expression following surgical truncation of the wing, in talpid 2 , limbless, and wingless mutant embryos, and in response to ZPA, Shh-N grafts and RAbead implants. The presence of cFHF-4 transcripts at the limb base in limbless and wingless embryos, and following limb truncations indicates that expression of cFHF-4 does not require limb outgrowth. However, in both limbless and wingless embryos, cFHF-4 is expressed at lower levels than in normal embryos. This lower expression may re¯ect a dependence on the limb bud for maintenance of cFHF-4 expression after its initial induction.
The expression of cFHF-4 at the anterior base of the limb in talpid 2 embryos initially suggested the idea that the normal A/ P asymmetry in cFHF-4 expression might be regulated by the ZPA and the Shh signaling pathway. However, the normal asymmetric expression of cFHF-4 in the limbless embryo, which does not express Shh in the limbs, argues against this model. Similarly, there is no effect on cFHF-4 expression when anterior limb buds were engrafted with stage 19±20 ZPA tissue, cells that expressed Shh-N protein, or beads soaked in RA. Results from the RA experiments, in which partial shoulder duplications were observed in the absence of ectopic cFHF-4 expression, suggest that cFHF-4 may not be involved in normal girdle development. Furthermore, girdle morphogenesis is regulated by signals from anterior proximal limb tissue, where cFHF-4 is not expressed (Oliver et al., 1990; Hoffman et al., 1998) .
In limbless and wingless embryos cFHF-4 expression also remains dorsally restricted. By contrast, the expression of Wnt-7a and Lmx-1 is expanded ventrally in both mutants and the resulting limbs are largely dorsalized (Grieshammer et al., 1996; Ros et al., 1996; Kim and Fallon, unpublished observations) . Taken together, these observations on A/P and D/V patterning of FHF-4 expression suggest that the relevant spatial signals arise from the lateral plate and/or the early limb ®eld rather than from the developing limb itself.
Innervation pattern and cFHF-4 expression in talpid 2 and limbless embryos
In talpid 2 embryos, which have an anteriorly expanded limb ®eld, there is an expansion of both the brachial plexus and cFHF-4 expression, suggesting that these processes are coordinately altered. In early talpid 2 limbs, axons also fail to fasci- culate and migrate properly, resulting in innervation by a large number of small diameter nerves that enter limb tissue in regions normally devoid of innervation. The limbless innervation pattern suggests that plexus formation and the initial sorting of axons into dorsal and ventral branches occurs independently of limb outgrowth and of cShh and cFgf-8 expression. Unfortunately, the innervation pattern cannot be examined at later stages, since the limb buds regress after stage 23. In the sciatic plexus of limbless embryos there is a loss of contribution from spinal nerves LS7 and LS8, and the axons from these two nerves appear disorganized and fail to enter peripheral tissue. In wild-type embryos, the dorsal mesoderm overlaying this region shows cFHF-4 expression, but this expression is absent in limbless embryos.
3.3. Induction of cFHF-4 by FGF-2: implications for axonal guidance cFHF-4 is ectopically expressed in response to FGF-2 bead implants. The induction by FGF-2 beads of cFHF-4 expression in either the presence or the absence of signi®-cant ectopic limb bud outgrowth suggests that these two processes are separable, a conclusion that was also drawn from the limb ablation experiments and the characterization of wingless and limbless embryos. In most cases, FGF-2 beads were able to induce visible alterations in axonal trajectories within the¯ank, and these alterations were con®ned to the ventral axons which were able to come together and form a plexus-like structure at different positions along the¯ank. Aberrant axon trajectories were present distal to the FGF-2 bead (indicating that FGF-2 was not acting directly as an attractant), and were observed only beneath tissue expressing ectopic cFHF-4.
The asymmetric pattern of ectopic cFHF-4 and the innervation defects induced by FGF-2 beads are likely to be mediated by a partial activation of the limb program. However, both phenomena are observed in the absence of cShh and cHoxD13 expression, further supporting the conclusion from the limbless embryos that there is a dissociation of signi®cant parts of the limb development program from the induction of cFHF-4 expression and formation of plexus-like structures.
Misexpression of either of the two FHF-4 isoforms does not lead to any visible alterations in limb and¯ank innervation or chondrogenesis, suggesting that ectopic FHF-4 alone is not suf®cient to alter these processes. Thus the question of whether axons alter their trajectories in response to cFHF-4 or whether induction of cFHF-4 and changes in axonal guidance are coregulated but independent of each other remains open. The data presented here show that the two processes are highly correlated, and is therefore suggestive of a causal relationship between them.
Materials and methods
FGF-2 bead implantations
Approximately 25 heparin-acrylic beads (H5263, Sigma) were incubated with 4 ml of 0.5 mg/ml FGF-2 (a gift of Dr A. Gosh) in PBS for 1 h at room temperature, with gentle agitation. Beads were implanted in stage 13±16 embryos, at different positions along the¯ank lateral plate mesoderm (LPM), under the ectoderm (throughout the text, the Hamburger and Hamilton (1951) staging system will be used). For full limb induction, stage 13±14 embryos were used; to induce small outgrowths, the beads were implanted at stages 15±16. Beads were also implanted in the anterior mesoderm of the right wing of stage 19±20 embryos, or in the mesoderm of the nasal pit region in stage 20±21 embryos. Embryos were analyzed at stages 27±29 for changes in gene expression by in situ hybridization.
For the limbless bead implantations, 1 or 2 FGF-2 beads were implanted into the mesoderm of the right wings of stage 20 embryos (n 6). Embryos were allowed to develop for 24 h before processing them for in situ hybridization or TuJ1 staining.
All-trans retinoic acid (RA) bead implantations
AG1-X2 formate beads (BioRad 140-1231) were incubated with 0.5 mg/ml or 0.1 mg/ml of RA (Sigma) in DMSO for 1 h at room temperature in the dark, with agitation. The beads were then rinsed in phosphate-buffered saline (PBS) and implanted into the right wings of stage 20±21 embryos, in the proximal anterior mesoderm. Embryos were analyzed for changes in gene expression by in situ hybridization 36±48 h after grafting, or embryos were allowed to develop to day 9±10 for cartilage staining.
Grafts of cells expressing Shh-N cDNA
Shh-N:COS cells were transiently cotransfected with a pCIS expression plasmid encoding the N-terminal product of the Shh gene (Chang et al., 1994) , essentially as described in Mun Äoz-Sanjua Ân et al. (1999) . Pellets of cells were grafted into the anterior proximal wing mesoderm of stage 19±20 embryos, and the embryos were analyzed for changes in gene expression 24±36 h after grafting.
Immunostaining with anti-tubulin mAb TuJ1
Immunostaining to detect b-tubulin with the TuJ1 antibody (a gift of Dr A. Frankfurter; Moody et al., 1989 ) was performed essentially as described in Burke and Tabin (1996) . In general, embryos were eviscerated prior to treatment. After ®xation in 4% PFA/PBS and methanol treatment, embryos were treated with proteinase K (10 mg/ml ®nal concentration) for the following times at room temperature: stages 20±22, 5 min; stages 22±26, 8 min; stages 26±30, 10±12 min. Embryos were immediately rinsed twice in 50 mM glycine (pH 7.25) for 10 min each, and then washed in PBS/0.1% Triton X-100 for 30 min each wash. Embryos were blocked in 10% normal goat serum (Vector) in PBS/0.5% Triton X-100. Anti TuJ1 mAb was added in blocking media at a 1:400 dilution. Secondary anti-mouse IgG/HRP (Vector) was used at a 1:200 dilution in blocking media. All washes were done in PBS/0.5% Triton X-100.
For double staining with TuJ1 antibody and whole-mount in situ hybridization, embryos were ®rst processed for in situ hybridization, then dehydrated through a methanol series, incubated with 5% H 2 O 2 in methanol for 1.5 h, rehydrated again, and taken into the immunostaining protocol at the blocking step. Embryos were equilibrated and cleared through a glycerol/PBS series, and stored in 80% glycerol.
Whole-mount in situ hybridization experiments
A riboprobe detecting all cFHF-4 splice isoforms (exons 2±5, Mun Äoz-Sanjua Ân et al., 2000) was synthesized from templates prepared by polymerase chain reaction (PCR) ampli®cation with an antisense primer that contained a T3 promoter sequence at its 5 H end. One hundred nanograms of the PCR product was used for in vitro transcription with T3 RNA polymerase in the presence of digoxygenin UTP. The whole-mount in situ hybridization was performed essentially as described in Li et al. (1994) .
The plasmid containing the cLmx-1 gene was a gift of J.C. Izpisua-Belmonte, the cShh plasmid was a gift of P.A. Beachy, the cHoxD13 plasmid was a gift of C. Tabin, the cRALDH-2 plasmid was a gift of T.M. Jessell, and the cRAR-beta-2 probe was a gift of S. Smith.
Zone of polarizing activity (ZPA) grafts
The ZPA region of stage 18±20 wings was removed as described in Tickle (1981) and ZPA fragments were grafted to a slit made in the anterior proximal mesoderm of stage 19±20 legs. Embryos were analyzed 48 h later for changes in gene expression and preaxial outgrowth.
Misexpression of FHF-4 isoforms
cFHF-4(1B) and mFHF-4(1A) were myc-tagged (Mun Äoz-Sanjua Ân et al., 2000) , and inserted into the RCAS(A) replication-competent retrovirus as described (Morgan and Fekete, 1995) . The mFHF-4(1A) cDNA was used for these experiments instead of cFHF-4(1A) because the ®rst 11 amino acids of the cFHF-4(1A) coding region have not been identi®ed (Mun Äoz-Sanjua Ân et al., 2000) . The mFHF-4(1A) and cFHF-4(1A) isoforms share 95% identity at the amino acid level.
Expression of the FHF-4 isoforms was assayed by immunostaining of either COS cells transfected with the RCAS constructs or chick embryonic ®broblasts (CEFs) infected with the viral constructs with an anti-myc mAb (Evan et al., 1985) , as described in Mun Äoz-Sanjua Ân et al. (2000) . Expression of the hFHF-1(1A)/RCAS(A) isoform was assayed in hFHF-1(1A)/RCAS(A) infected CEFs by immunostaining with anti-FHF-1 antibodies, as described in Smallwood et al. (1996) .
The cFHF-4(1B)myc/RCAS and mFHF-4(1A)myc/ RCAS constructs were misexpressed by grafting infected CEF cells into the¯ank LPM and anterior right leg ®eld at stages 13±15, as described in Mun Äoz-Sanjua Ân et al. (1999) . The cFHF-4(1B)myc/RCAS virus was misexpressed by injecting high titer stock (5 £ 10 8 pfu/ml; Morgan and Fekete, 1995) into the right-side LPM of stage 12±15 embryos. Viral spread was assayed by wholemount in situ hybridization with riboprobes against chicken or mouse FHF-4 sequences. Embryos were analyzed at stages 27±31 for innervation patterns, or allowed to develop to day 10 for cartilage preparations. SPAFAS-quality, pathogen-free eggs (B&E farms, Stevens, PA) were used for the viral misexpression studies.
